Annual ROE
117.07%
+68.63%+141.68%
December 31, 2023
Summary
- As of February 12, 2025, CDT annual return on equity is 117.07%, with the most recent change of +68.63% (+141.68%) on December 31, 2023.
- During the last 3 years, CDT annual ROE has risen by +55.53% (+90.23%).
- CDT annual ROE is now at all-time high.
Performance
CDT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
334.16%
+93.94%+39.11%
September 29, 2024
Summary
- As of February 12, 2025, CDT quarterly return on equity is 334.16%, with the most recent change of +93.94% (+39.11%) on September 29, 2024.
- Over the past year, CDT quarterly ROE has increased by +294.76% (+748.12%).
- CDT quarterly ROE is now at all-time high.
Performance
CDT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CDT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +141.7% | +748.1% |
| 3 y3 years | +90.2% | +748.1% |
| 5 y5 years | +90.2% | +748.1% |
CDT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +141.7% | at high | +4502.8% |
| 5 y | 5-year | at high | +141.7% | at high | +4502.8% |
| alltime | all time | at high | +141.7% | at high | +4502.8% |
Conduit Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 334.16%(+39.1%) |
| Jun 2024 | - | 240.22%(+398.5%) |
| Mar 2024 | - | 48.19%(+563.8%) |
| Dec 2023 | 117.07% | 7.26%(-81.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | 39.40%(-32.8%) |
| Jun 2023 | - | 58.65%(+16.3%) |
| Mar 2023 | - | 50.42%(+17.4%) |
| Dec 2022 | 48.44%(-21.3%) | 42.96% |
| Dec 2021 | 61.54% | - |
FAQ
- What is Conduit Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals annual ROE year-on-year change?
- What is Conduit Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals quarterly ROE year-on-year change?
What is Conduit Pharmaceuticals annual return on equity?
The current annual ROE of CDT is 117.07%
What is the all time high annual ROE for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high annual return on equity is 117.07%
What is Conduit Pharmaceuticals annual ROE year-on-year change?
Over the past year, CDT annual return on equity has changed by +68.63% (+141.68%)
What is Conduit Pharmaceuticals quarterly return on equity?
The current quarterly ROE of CDT is 334.16%
What is the all time high quarterly ROE for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high quarterly return on equity is 334.16%
What is Conduit Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, CDT quarterly return on equity has changed by +294.76% (+748.12%)